Molecole per mastiti da Gram positivi (Clinical Breakpoints)
Elenco di possibili molecole antibiotiche per la valutazione della sensibilità in agenti batterici patogeni Gram positivi isolati nel bovino. | ||||||||||||||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Beta Lattamici | Penicillina Staphylococcus spp (HD) | P | NP | P | NP | NP | NP | P | NP | P | NP | NP | NP | |||
Penicillina Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Penicillina Streptococcus beta haemolytic group (HD) | NP | NP | NP | P | NP | NP | P | NP | P | NP | NP | NP | ||||
Penicillina Streptococcus agalactiae | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Penicillina Streptococcus viridans group (HD) | NP | NP | NP | P | P | P | NP | NP | NP | NP | NP | NP | ||||
Penicillina Enterococcus spp | P | NP | P | P | NP | P | NP | NP | NP | NP | NP | P | ||||
Cefoxitina^ Staphylococcus spp (HD) | P | NP | P | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Cefoxitina^ Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
(Ceftiofur) Staphylococcus aureus | P | P | P | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
(Fluoro)chinolonici | Ciprofloxacina Staphylococcus spp | NP | NP | NP | P | p | P | NP | NP | NP | NP | NP | NP | |||
Ciprofloxacina Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Enrofloxacina Staphylococcus spp | NP | NP | NP | NP | NP | NP | P | NP | P | NP | NP | NP | ||||
Enrofloxacina Streptococcus spp | NP | NP | NP | NP | NP | NP | P | NP | P | NP | NP | NP | ||||
Ciprofloxacina Streptococcus agalactiae | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Aminoglicosidi (Aminociclitoli) | Kanamicina Staphylococcus spp | NP | NP | NP | NP | NP | NP | P | NP | P | NP | NP | NP | |||
Kanamicina Staphylococcus aureus(HD) | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Gentamicina Staphylococcus spp (HD) | P | P | P | P | P | P | P | NP | P | NP | NP | NP | ||||
Gentamicina Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Gentamicina Streptococcus agalactiae | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Lincosamidi | Pirlimicina Staphylococcus aureus | P | NP | P | NP | NP | NP | NP | NP | NP | NP | NP | NP | |||
Pirlimicina Streptococcus agalactiae, dysgalactiae, uberis | P | NP | P | NP | NP | NP | NP | NP | NP | NP | NP | NP | ||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Macrolidi | Eritromicina Staphylococcus spp | P | P | P | NP | NP | NP | P | NP | P | NP | NP | NP | |||
Eritromicina Enterococcus spp (HD) | P | P | P | NP | NP | NP | NP | NP | NP | NP | NP | NP | ||||
Eritromicina Streptococcus spp (HD) | P | P | P | NP | NP | NP | P | NP | P | NP | NP | NP | ||||
Eritromicina Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Eritromicina Streptococcus agalactiae | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Eritromicina Streptococcus uberis | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Eritromicina Streptococcus dysgalactiae | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Eritromicina Enterococcus faecium/faecalis | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Rifaximine | Rifampicina Staphylococcus spp (HD) | NP | NP | NP | P | P | P | NP | NP | NP | NP | NP | NP | |||
Rifampicina Enterococcus spp (HD) | NP | NP | NP | P | P | P | NP | NP | NP | NP | NP | NP | ||||
Rifampicina Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Rifampicina Enterococcus faecalis | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Sulfonamidi | Sulfonamidi Staphylococcus spp | NP | NP | NP | NP | NP | NP | P | NP | P | NP | NP | NP | |||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Trimethoprim | Trimethoprim Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | |||
Trimethoprim Staphylococcus spp | NP | NP | NP | NP | NP | NP | P | NP | P | NP | NP | NP | ||||
Mastiti Gram +vi $ | CLSI VET 01S-Ed 6 (HD) | CLSI M100 S33 | CA-SFM VET 2023 | EUCAST ECOFF 2023 | ||||||||||||
S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | S≤ | I (range) | R≥ | |||||
Trimethoprim-sulfamethoxazole | Staphylococcus spp (HD) | P | NP | P | P | NP | P | P | NP | P | NP | NP | NP | |||
Streptococcus spp | NP | NP | NP | NP | NP | NP | P | NP | P | NP | NP | NP | ||||
Streptococcus agalactiae | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Streptococcus dysgalactiae | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Streptococcus uberis | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P | ||||
Staphylococcus aureus | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | NP | P |
Note:
- P: Clinical breakpoint/Epidemiological cutoff presente
- NP: Clinical breakpoint/Epidemiological cutoff non presente
- HD: Human-derived (breakpoints derivati dallo Standard Umano, come da documento CLSI VET)
- $ Per Staphyloccus aureus, Streptococcus, altri Gram +vi (Trueperella pyogenes)
- ^ Per Staphylococcus aureus
- Gli antibiotici tra parentesi sono da considerarsi facoltativi